Search results
Mr. Gordon Binder is the Chairman of the Board of Directors of NEUVOGEN. He was Chief Executive Officer of Amgen, Inc. the world’s largest biotech company, from 1988 through 2000. During Mr. Binder’s tenure as CEO, the company grew from 400 employees to 7,000 to rank within the top 20 pharmaceutical companies in worldwide revenues, the top ...
3 mar 2002 · Almost a year after starting a local biomedical venture capital firm, retired Amgen Inc. Chairman Gordon Binder is close to raising his first fund, which is set at $100 million, sources say.
12 cze 2002 · Coastview Capital Team6 Team Members. Coastview Capital has 6 team members, including current Managing Director, Gordon Binder.
Gordon and Adele Binder. SOURCE OF WEALTH: Coastview Capital, Amgen. FUNDING AREAS: Education & Youth, Policy, Arts & Culture, Health & Human Services, Jewish Causes. OVERVIEW: Gordon Binder and his wife Adele conduct their philanthropy through the Binder Foundation, which, according to available tax filings, gave away around $1 million in 2017.
17 sie 2021 · After retiring from Amgen, Mr. Binder founded Coastview Capital LLC, a biotech venture capital firm. Mr. Binder currently serves as Chairman of the Board of Directors of NEUVOGEN, Inc., a...
After retiring from Amgen, Mr. Binder founded Coastview Capital LLC, a biotech venture capital firm. He is a graduate of Purdue University and holds an MBA from Harvard Business School, where he was a Baker Scholar.
Alumni Achievement Awards 2000: Gordon M. Binder Initiatives focus on societal challenges that are too complex for any one discipline or industry to solve alone. ǁ
